142 related articles for article (PubMed ID: 8658779)
1. Erythropoietin, interleukin-3, interleukin-11, and GM-CSF in posttransplant erythrocytosis treated with enalapril.
Hu RH; Lee PH; Lee CJ
Transplant Proc; 1996 Jun; 28(3):1545-7. PubMed ID: 8658779
[No Abstract] [Full Text] [Related]
2. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU
Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809
[No Abstract] [Full Text] [Related]
3. The beneficial effect of enalapril on erythrocytosis after renal transplantation.
Conlon PJ; Farrell J; Donohoe J; Walshe JJ
Transplantation; 1993 Jul; 56(1):217-9. PubMed ID: 8333046
[No Abstract] [Full Text] [Related]
4. Preventive effect of enalapril on erythrocytosis after renal transplantation.
Rhee SR; Park SK; Kang SK; Kim SH; Cho BH; Kim JH
Transplant Proc; 1996 Jun; 28(3):1555-6. PubMed ID: 8658783
[No Abstract] [Full Text] [Related]
5. New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients.
Sauron C; Berthoux P; Berthoux F; Alamartine E; Diab N; Broyet C; Hacini J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1032-3. PubMed ID: 8382847
[No Abstract] [Full Text] [Related]
6. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
[TBL] [Abstract][Full Text] [Related]
7. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
[TBL] [Abstract][Full Text] [Related]
8. Enalapril: safe and effective therapy for posttransplant erythrocytosis.
Gaston RS; Julian BA; Barker CV; Diethelm AG; Curtis JJ
Transplant Proc; 1993 Feb; 25(1 Pt 2):1029-31. PubMed ID: 8442029
[No Abstract] [Full Text] [Related]
9. Efficacy of enalapril in the treatment of erythrocytosis in patients with renal allografts.
Carvalho MF; Balbi AL; Corrêa LA; Soares VA
Transplant Proc; 1996 Dec; 28(6):3377. PubMed ID: 8962316
[No Abstract] [Full Text] [Related]
10. Posttransplant erythrocytosis: a possible nonerythropoietin-mediated mechanism.
Morrone LF; Schena A; Di Paolo S; Stallone G; Schena FP
Transplant Proc; 1997; 29(1-2):223. PubMed ID: 9122971
[No Abstract] [Full Text] [Related]
11. Successful treatment of post-renal transplant erythrocytosis with enalapril.
Rostaing L; Boisseau M; Durand D; Huyn A; Lloveras JJ; Suc JM
Transplant Proc; 1993 Jun; 25(3):2325-6. PubMed ID: 8516915
[No Abstract] [Full Text] [Related]
12. Management of posttransplant erythrocytosis with enalapril.
Javid R; Ghahramani N; Malek-Hosseini SA; Behzadi S; Rais-Jalali GA
Transplant Proc; 1999 Dec; 31(8):3226. PubMed ID: 10616453
[No Abstract] [Full Text] [Related]
13. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines.
Morrone LF; Di Paolo S; Logoluso F; Schena A; Stallone G; Giorgino F; Schena FP
Transplantation; 1997 Sep; 64(6):913-8. PubMed ID: 9326420
[TBL] [Abstract][Full Text] [Related]
14. Correction of posttransplant erythrocytosis with enalapril.
Rell K; Koziak K; Jarzyo I; Lao M; Gaciong Z
Transplantation; 1994 Apr; 57(7):1059-63. PubMed ID: 8165703
[TBL] [Abstract][Full Text] [Related]
15. Use of aminophylline and enalapril in posttransplant polycythemia.
Mazzali M; Filho GA
Transplantation; 1998 Jun; 65(11):1461-4. PubMed ID: 9645803
[TBL] [Abstract][Full Text] [Related]
16. Plasma GM-CSF, IL-6, and IL-3 monitoring allows differentiation between infection and rejection in some renal transplant recipients: preliminary results of a retrospective study.
Daniel V; Pasker S; Reiss U; Weimer R; Wiesel M; Pomer S; Staehler G; Opelz G
Transplant Proc; 1993 Feb; 25(1 Pt 2):893-6. PubMed ID: 8382882
[No Abstract] [Full Text] [Related]
17. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
Hernández E; Morales JM; Andrés A; Ortuño B; Praga M; Alcazar JM; Fernández G; Rodicio JL
Transplant Proc; 1995 Aug; 27(4):2239-41. PubMed ID: 7652789
[No Abstract] [Full Text] [Related]
18. Effect of captopril in the treatment of erythrocytosis after renal transplantation.
Suh BY; Suh JD; Kwun KB
Transplant Proc; 1996 Jun; 28(3):1557-8. PubMed ID: 8658784
[No Abstract] [Full Text] [Related]
19. Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.
Yagisawa T; Toma H; Yaguchi H; Tomaru M; Iijima Y; Suzuki H; Nakada T
Int Urol Nephrol; 1997; 29(3):363-7. PubMed ID: 9285312
[TBL] [Abstract][Full Text] [Related]
20. Treatment of post-renal-transplant erythrosis: ACE inhibitors or theophylline?
Ben Hmida M; Hachicha J; Jarraya F; Kharrat M; Jarraya A
Transplant Proc; 1995 Oct; 27(5):2720-1. PubMed ID: 7482889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
